SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Hilbrich L.)
 

Search: WFRF:(Hilbrich L.) > (2007) > Glucose levels pred...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Held, C (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Gerstein, H C (author)
Yusuf, S (author)
show more...
Zhao, F (author)
Hilbrich, L (author)
Anderson, C (author)
Sleight, P (author)
Teo, K (author)
show less...
 (creator_code:org_t)
2007
2007
English.
In: Circulation. - 0009-7322 .- 1524-4539. ; 115:11, s. 1371-1375
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background— Patients with diabetes mellitus (DM) are at high risk of developing congestive heart failure (CHF). However, the relationships between glucose levels and CHF in people with or without a history of DM have not been well characterized. Methods and Results— We evaluated the associations between fasting plasma glucose and risk of hospitalization for CHF during follow-up in patients at high cardiovascular risk and without CHF enrolled in a large-scale clinical trials program. Baseline fasting plasma glucose levels were assessed in 31 546 high-risk subjects with 1 coronary, peripheral, or cerebrovascular disease or DM with end-organ damage who are participating in 2 ongoing parallel trials evaluating the effects of telmisartan, ramipril, or their combination (Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]; n=25 620) and the effects of telmisartan against placebo in angiotensin-converting enzyme–intolerant patients (Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease [TRANSCEND]; n=5926). Interim analyses blinded for randomized treatment were performed to compare baseline fasting plasma glucose with the adjusted CHF event rate at a mean follow-up of 886 days. Multivariable Cox regression models were performed, and associations were reported as hazard ratios and 95% confidence intervals. Among all subjects (mean age, 67 years; 69% men), of whom 11 708 (37%) had known DM and 1006 (3.2%) had newly diagnosed DM at baseline, 668 patients were hospitalized for CHF during follow-up. After adjustment for age and sex, a 1-mmol/L-higher fasting plasma glucose was associated with a 1.10-fold-increased risk of CHF hospitalization (95% confidence interval, 1.08 to 1.12; P<0.0001). The association persisted after adjustment for age, sex, smoking, previous myocardial infarction, hypertension, waist-to-hip ratio, creatinine, DM, and use of aspirin, ß-blockers, or statins (hazard ratio, 1.05; 95% confidence interval, 1.02 to 1.08; P<0.001). Conclusions— Fasting plasma glucose is an independent predictor of hospitalization for CHF in high-risk subjects. These data provide theoretical support for potential direct beneficial effects of glucose lowering in reducing the risk of CHF and suggests the need for specific studies targeted at this issue.

Keyword

Aged
Angiotensin-Converting Enzyme Inhibitors/therapeutic use
Benzimidazoles/therapeutic use
Benzoates/therapeutic use
Blood Glucose
Diabetes Complications/blood/epidemiology
Drug Therapy; Combination
Fasting
Female
Heart Failure/*blood/drug therapy/*epidemiology
Hospitalization/*statistics & numerical data
Humans
Hyperglycemia/*blood/*epidemiology
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Ramipril/therapeutic use
Risk Factors
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view